PU✚PubMed·Clinical trial·Clinical audiology·7d agoAtorvastatin for the Prevention of Cisplatin-Induced Ototoxicity: A Randomized Controlled TrialIf atorvastatin demonstrates significant protective efficacy in this RCT, oncology-audiology teams should consider evaluating it as an otoprotective co-treatment — full results and effect size must be reviewed before any protocol change.
PU¶PubMed·Journal article·Clinical audiology·3w agoCisplatin-Induced Ototoxicity in Head and Neck Cancer: A Systematic Review of Current Evidence, Clinical Implications, and the Need for Standardized MonitoringAudiologists working with head and neck cancer patients should advocate for standardized ototoxicity monitoring protocols, as this systematic review highlights wide variation in current practice and a clear unmet need.+Save
Hearing Health Matters·Press release·Pediatric·2mo agoJapanese PEDMARK Study Reports Significant Reduction in Cisplatin-Related Hearing LossThis Phase 2 result from Japan adds geographic replication to existing evidence for sodium thiosulfate as a hearing protectant in pediatric cisplatin patients, but audiologists should await peer-reviewed publication and regulatory guidance before changing referral or monitoring...+Save
PU¶PubMed·Journal article·Clinical audiology·2mo agoEfficacy and Toxicity of Triweekly Versus Weekly Cisplatin in Concurrent Chemoradiotherapy for Nasopharyngeal CarcinomaAudiologists involved in ototoxicity monitoring programs for head and neck cancer patients should note this comparison, as dosing schedule may influence the degree of cisplatin-related hearing damage — but the retrospective design limits definitive guidance.+Save
PU¶PubMed·Journal article·Research (general)·3mo agoGadd45a knockout alleviates cisplatin-induced hearing loss by inhibiting CXCL family protein expressionThis is a mouse study identifying a potential molecular target for preventing cisplatin-related hearing damage; no actionable change in clinical practice is warranted at this stage.+Save
PU¶PubMed·Journal article·Tinnitus·3mo agoAuthor Reply to Letter to the Editor Regarding "Intratympanic Dexamethasone Efficacy in Preventing Cisplatin-Induced Tinnitus: A Randomized Controlled Phase IIIB Clinical Trial"This is an author reply to a letter to the editor and does not introduce new data; no change to current practice is warranted until the full exchange is evaluated in context of the original Phase IIIB trial findings.+Save
PU¶PubMed·Journal article·Research (general)·3mo agoComparative safety signals of carboplatin and cisplatin in lung cancer: a pharmacovigilance study based on FAERSAudiologists monitoring patients on platinum-based chemotherapy should note that cisplatin carries a stronger ototoxicity signal than carboplatin per this database study, reinforcing existing monitoring guidelines — no immediate practice change beyond current ASHA/AAA...+Save
PU¶PubMed·Journal article·Tinnitus·3mo agoRe: "Intratympanic Dexamethasone Efficacy in Preventing Cisplatin-Induced Tinnitus: A Randomized Controlled Phase IIIb Clinical Trial" by Moreno and BelinchonClinicians should read both the original Phase IIIb RCT and this correspondence carefully before adopting intratympanic dexamethasone as a routine protocol for preventing cisplatin-induced tinnitus, as the letter may highlight methodological or interpretive concerns.+Save
PU¶PubMed·Journal article·Clinical audiology·4mo agoExploring the usability of a point-of-care hearing screening by oncology registered nurses with adult cancer patients during Cisplatin chemotherapy - A convergent mixed methods studyPoint-of-care hearing screening by oncology nurses appears usable in Cisplatin chemotherapy settings, but adoption into audiology practice depends on validation of screening accuracy and integration with referral pathways — current evidence is insufficient to mandate a practice...+Save
PU¶PubMed·Journal article·Pediatric·4mo agoAvoiding Cisplatin-Related Hearing Loss, Including Implementing Sodium Thiosulfate as Otoprotectant Into Daily Pediatric Clinical Practice: Proceedings Based on Evidence and Expert Opinion From the Ototoxicity Taskforce of the SIOP Supportive Care NetworkAudiologists and oncology teams treating pediatric cisplatin patients should be aware of SIOP Ototoxicity Taskforce guidance supporting sodium thiosulfate as an otoprotectant, and advocate for its integration into institutional chemotherapy protocols.+Save
PU¶PubMed·Journal article·Research (general)·4mo agoMechanistic study of HES1/PI3K/Akt/mTOR signaling pathway in cisplatin-induced sensorineural hearing lossIdentifying the molecular mechanism behind cisplatin-induced hearing loss opens a potential therapeutic window to prevent ototoxicity (medication-related hearing damage) without compromising cancer treatment efficacy.+Save
PU¶PubMed·Journal article·Pediatric·5mo agoImpact of Cisplatin-Induced Hearing Loss on Quality of Life in Childhood Cancer SurvivorsAudiologists working with pediatric oncology patients should prioritize hearing monitoring during and after cisplatin treatment and proactively address rehabilitation needs, as irreversible hearing loss demonstrably impairs survivors' quality of life.+Save